Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sivelestat Sodium as an Adjunct to EVT in Acute Ischemic Stroke
NCT07552610Recruiting
- Sponsor
- Xuanwu Hospital
- Start
- Jun 2026
- Primary completion
- May 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in ischemic stroke comparing Sivelestat Sodium + Endovascular Thrombectomy with Placebo + Endovascular Thrombectomy (2 arms). Primary endpoint: Rate of modified Rankin Scale score of 0-2 at 90 days. Started Jun 2026; status: recruiting.
02
Drugs
sivelestat
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07552610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07552610.